Finance

Beta
Lists
JSPR:NASDAQ
Jasper Therapeutics Inc
$0.52
+6.01%
(+0.029) 1D
Jun 24, 12:07:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Open
$0.50
High
$0.52
Low
$0.50
Mkt. cap
14.30M
Avg. vol.
579.96K
Volume
124.65K
52-wk high
$7.19
52-wk low
$0.42
EPS
-$3.23
Beta
3.00
Shares outstanding
28.01M
No. of employees
22
Open
$0.50
High
$0.52
Low
$0.50
Mkt. cap
14.30M
Avg. vol.
579.96K
Volume
124.65K
52-wk high
$7.19
52-wk low
$0.42
EPS
-$3.23
Beta
3.00
Shares outstanding
28.01M
No. of employees
22
News stories
From sources across the web
About Jasper Therapeutics Inc
CEO-
Employees22
Founded2018
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websitejaspertx.com
Analyst Ratings
Based on 6 analysts giving stock ratings to JSPR in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current $0.52
$20.00 (+3,758.02%)
Average
$7.88 (+1,420.06%)
Lowest
$1.50 (+189.35%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Matt Phipps
William Blair
Hold
Maintained
-
-
06/01/2026
Leonid Timashev
RBC Capital
Hold
Maintained
$3.00
+478.7%
05/14/2026
Yaron Werber
TD Cowen
Hold
Downgraded
-
-
05/15/2026
David Dai
UBS
Hold
Maintained
$1.50
+189.4%
04/02/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$7.00
+1,250.3%
04/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$20.00
+3,758%
03/30/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+3,179.3%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21.20M
13.10M
10.85M
5.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.88M
4.26M
4.49M
5.14M
Operating expense
27.08M
17.36M
15.35M
10.95M
Total operating expenses
27.08M
17.36M
15.35M
10.95M
Operating income
-27.08M
-17.36M
-15.35M
-10.95M
Other non operating income
-84.00K
88.00K
6.40M
9.61M
EBT including unusual items
-26.72M
-18.74M
-9.10M
-1.17M
EBT excluding unusual items
-26.72M
-16.93M
-8.61M
-1.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.72M
-18.74M
-9.10M
-1.17M
Net profit margin
-
-
-
-
Earnings per share
-1.74
-1.25
-0.54
-0.38
Interest and investment income
437.00K
342.00K
338.00K
164.00K
Interest expense
-
-
-
-
Net interest expenses
437.00K
342.00K
338.00K
164.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.82M
-17.13M
-15.06M
-10.93M
Gain or loss from assets sale
2.00K
-2.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer